The influential factors and non-pharmacological interventions of cognitive impairment in children with ischemic

Gang Xu1, Fuchun Hao2, Weiwei Zhao3

  • 1Rehabilitation Branch, Tianjin Children's Hospital/Tianjin University Children's Hospital, Tianjin, China.

Frontiers in Neurology
|January 2, 2023
PubMed

Insights

Pediatric ischemic stroke leads to cognitive impairment in many children. Current non-pharmacological treatments show weak evidence, necessitating further research for effective interventions.

Area of Science:

  • Pediatric Neurology
  • Neurorehabilitation
  • Cognitive Science

Background:

  • Pediatric ischemic stroke prevalence increased 35% from 1990-2013.
  • Cognitive impairment affects 20-50% of affected children, impacting language, memory, and processing speed.
  • Limited evidence-based treatments exist due to patient heterogeneity.

Purpose of the Study:

  • To review non-pharmacological rehabilitation interventions for cognitive impairment post-pediatric ischemic stroke.
  • To identify current research gaps and future directions in pediatric stroke cognitive rehabilitation.

Main Methods:

  • Systematic literature search of Web of Science, Scopus, and PubMed up to January 2022.
  • Focused on non-pharmacological interventions for cognitive deficits in pediatric ischemic stroke survivors.

Main Results:

  • Explored interventions include exercise, psychological therapy, neuromodulation, computer-based training, BCI, VR, music therapy, and acupuncture.
  • Only psychological intervention and neuromodulation strategies were found for childhood stroke.
  • Evidence for the efficacy of these interventions is currently weak.

Conclusions:

  • Further research is crucial to develop effective interventions for pediatric cognitive function.
  • Neuroimaging and electrophysiological techniques are valuable for future studies.
  • Large, multi-center prospective studies are needed for evidence-based treatment guidance.
Abstract

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
180
Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
98
Environmental Influences on Intelligence01:29

Environmental Influences on Intelligence

Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children...
393
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K